相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multivariate patent analysis-Using chemometrics to analyze collections of chemical and pharmaceutical patents
Rickard Sjogren et al.
JOURNAL OF CHEMOMETRICS (2020)
Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres
C. Crespillo-Andujar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Chagas Disease in the United States: a Public Health Approach
Caryn Bern et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment
Ana Lia Mazzeti et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
TechNet: Technology semantic network based on patent data
Serhad Sarica et al.
EXPERT SYSTEMS WITH APPLICATIONS (2020)
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Olivier J. Wouters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs
Alec O'Keeffe et al.
MICROORGANISMS (2020)
Praziquantel-loaded solid lipid nanoparticles: Production, physicochemical characterization, release profile, cytotoxicity and in vitro activity against Schistosoma mansoni
Luciana Nalone Andrade et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.
Eduardo Seiji Yamamoto et al.
BIOORGANIC CHEMISTRY (2020)
ZIF-8 as a promising drug delivery system for benznidazole: development, characterization, in vitro dialysis release and cytotoxicity
Leslie Raphael de Moura Ferraz et al.
SCIENTIFIC REPORTS (2020)
Praziquantel-Clays as Accelerated Release Systems to Enhance the Low Solubility of the Drug
Ana Borrego-Sanchez et al.
PHARMACEUTICS (2020)
Contributions from the Critical Success Factors model to analysis of the management of Product Development Partnerships in a government laboratory
Daniela Rangel Affonso Fernandes et al.
CADERNOS DE SAUDE PUBLICA (2020)
Burden of Chagas disease in Brazil, 1990-2016: findings from the Global Burden of Disease Study 2016
Francisco Rogerlandio Martins-Melo et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2019)
Drugs and vaccines in the 21st century for neglected diseases
Leonardo L. G. Ferreira et al.
LANCET INFECTIOUS DISEASES (2019)
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
Xuemei Ge et al.
PHARMACEUTICS (2019)
P38 Identification of Nifurtimox metabolites in urine of pediatric Chagas disease patients by UHPLC-MS/MS
CA Pérez Montilla et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2019)
An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of Trypanosoma cruzi That Depicts the Multifunctionality and Dysfunctionality of T Cells
Jose Mateus et al.
FRONTIERS IN IMMUNOLOGY (2019)
Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
Mahshid Mostafavi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Polymer-Based Nanoparticle Strategies for Insulin Delivery
Shazia Mansoor et al.
POLYMERS (2019)
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications
Shuo Chen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
The effects of endoplasmic reticulum stressors, tunicamycin and dithiothreitol on Trypanosoma cruzi
Jana Messias Sandes et al.
EXPERIMENTAL CELL RESEARCH (2019)
Optimization models for financing innovations in green energy technologies
R. R. Tan et al.
RENEWABLE & SUSTAINABLE ENERGY REVIEWS (2019)
Technology maturity assessment of micro and nano manufacturing processes and process chains
Pierre C. Vella et al.
PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART B-JOURNAL OF ENGINEERING MANUFACTURE (2018)
Chemical Mapping of Leishmania Infection in Live Cells by SERS Microscopy
Vesna Zivanovic et al.
ANALYTICAL CHEMISTRY (2018)
Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail
C. Crespillo-Andujar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Cyclodextrins: structure, physicochemical properties and pharmaceutical applications
Phatsawee Jansook et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment
E. Aldasoro et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Comprehensive review of cardiovascular toxicity of drugs and related agents
Premysl Mladenka et al.
MEDICINAL RESEARCH REVIEWS (2018)
Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes
Phennapha Saokham et al.
MOLECULES (2018)
Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review
Caue Benito Scarim et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2018)
Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(L-glutamic acid-co-L-phenylalanine)
Chenguang Yang et al.
BIOMATERIALS SCIENCE (2018)
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome (R) and AmBisome (R) in murine cutaneous leishmaniasis
Gert-Jan Wijnant et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
Rokaya O. Amara et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major
Tahereh Zadeh Mehrizi et al.
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2018)
Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi
Cristina Fonseca-Berzal et al.
PARASITOLOGY RESEARCH (2018)
Hepatic changes by benznidazole in a specific treatment for Chagas disease
Tycha Bianca Sabaini Pavan et al.
PLOS ONE (2018)
Burden of leishmaniasis in Brazil and federated units, 1990-2016: Findings from Global Burden of Disease Study 2016
Juliana Maria Trindade Bezerra et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia
Liliana Lopez et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis
Laura M. Alcantara et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)
Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs
Ganesan Poovi et al.
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs
Anke E. Kip et al.
CLINICAL PHARMACOKINETICS (2018)
A deep analysis of chemical structure-based patent searching in the Derwent index space
Andreas Barth
WORLD PATENT INFORMATION (2018)
Development and physicochemical characterization of solid dispersions containing praziquantel for the treatment of schistosomiasis
P. R. Dametto et al.
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY (2017)
Murine models susceptibility to distinct Trypanosoma cruzi I genotypes infection
Cielo M. Leon et al.
PARASITOLOGY (2017)
Chagas disease in Europe: A review for the internist in the globalized world
Spinello Antinori et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)
Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment
Chun Y. Wong et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis
Rishikesh Kumar et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery
M. C. Teixeira et al.
PROGRESS IN LIPID RESEARCH (2017)
Discovering new technology opportunities based on patents: Text-mining and F-term analysis
Kisik Song et al.
TECHNOVATION (2017)
Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis
Sostenes Mistro et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2017)
Patent landscape of neglected tropical diseases: an analysis of worldwide patent families
Folahanmi Tomiwa Akinsolu et al.
GLOBALIZATION AND HEALTH (2017)
Assessing Early-Stage CO2 utilization Technologies-Comparing Apples and Oranges?
Arno W. Zimmermann et al.
ENERGY TECHNOLOGY (2017)
Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies
Louis-Albert Tchuem Tchuente et al.
INFECTIOUS DISEASES OF POVERTY (2017)
Niosomes: a review of their structure, properties, methods of preparation, and medical applications
Pei Ling Yeo et al.
ASIAN BIOMEDICINE (2017)
Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine
Vinicius Barros Ribeiro da Silva et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Nanopharmaceuticals as a solution to neglected diseases: Is it possible?
German A. Islan et al.
ACTA TROPICA (2017)
Identifying product opportunities using collaborative filtering-based patent analysis
Janghyeok Yoon et al.
COMPUTERS & INDUSTRIAL ENGINEERING (2017)
The technology networks and development trends of university-industry collaborative patents
Shu-Hao Chang
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2017)
Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance
Nuno Vale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetics and Tissue Distribution of Benznidazole after Oral Administration in Mice
Luisa Perin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Monitoring emerging technologies for technology planning using technical keyword based analysis from patent data
Junegak Joung et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2017)
A global systematic review of Chagas disease prevalence among migrants
Erin E. Conners et al.
ACTA TROPICA (2016)
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Naomi Aronson et al.
CLINICAL INFECTIOUS DISEASES (2016)
Novel drug discovery for Chagas disease
Carolina B. Moraes et al.
EXPERT OPINION ON DRUG DISCOVERY (2016)
Topical drug delivery systems: a patent review
Deepinder Singh Malik et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya
Isaac O. Onkanga et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2016)
Thirty years with cyclodextrins
Dominique Duchene et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Emerging Frontiers in Drug Delivery
Mark W. Tibbitt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination
Lan-Gui Song et al.
PARASITOLOGY RESEARCH (2016)
Technology Trends in Biodegradable Polymers: Evidence from Patent Analysis
David Elvers et al.
POLYMER REVIEWS (2016)
Estimating the Burden of Chagas Disease in the United States
Jennifer Manne-Goehler et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Technology Clusters Exploration for Patent Portfolio through Patent Abstract Analysis
Gabjo Kim et al.
SUSTAINABILITY (2016)
Reversible cardiomyopathy secondary to Amphotericin-B
Antonio Carlos Bandeira et al.
MEDICAL MYCOLOGY CASE REPORTS (2016)
Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers
I. Molina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Miltefosine and BODIPY-labeled alkylphosphocholine with leishmanicidal activity: Aggregation properties and interaction with model membranes
Marina Berardi Barioni et al.
BIOPHYSICAL CHEMISTRY (2015)
Tolerance of Benznidazole in a United States Chagas Disease Clinic
David A. Miller et al.
CLINICAL INFECTIOUS DISEASES (2015)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Delivering nanomedicines to patients: A practical guide
Mike A. W. Eaton et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Mitigating risk in academic preclinical drug discovery
Jayme L. Dahlin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Translational challenges of animal models in Chagas disease drug development: a review
Eric Chatelain et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis
Emily Rose Mears et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Prevalence of Chagas Disease in Latin-American Migrants Living in Europe: A Systematic Review and Meta-analysis
Ana Requena-Mendez et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes
Garima Sharma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa
A. Randjelovic et al.
SOUTH AFRICAN FAMILY PRACTICE (2015)
Novel drug therapies in myeloid leukemia
Gillian A. Horne et al.
PHARMACEUTICAL PATENT ANALYST (2015)
Bridging the Valley of Death A Success Story on Danish Funding Schemes Paving a Path from Technology Readiness Level 1 to 9
Soren Debois et al.
SECOND INTERNATIONAL WORKSHOP ON SOFTWARE ENGINEERING RESEARCH AND INDUSTRIAL PRACTICE SER&IP 2015 (2015)
Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats
Rajesh Parikh et al.
DRUG DELIVERY (2014)
Nanotechnology-based drug delivery systems and herbal medicines: a review
Bruna Vidal Bonifacio et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
An overview of clinical and commercial impact of drug delivery systems
Aaron C. Anselmo et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Controlled drug delivery systems: Past forward and future back
Kinam Park
JOURNAL OF CONTROLLED RELEASE (2014)
Revisiting the concept of hepatosplenic schistosomiasis and its challenges using traditional and new tools
Jose Roberto Lambertucci
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2014)
ANIMAL MODELS FOR THE STUDY OF LEISHMANIASIS IMMUNOLOGY
Elsy Nalleli Loria-Cervera et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2014)
Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities
Martial L. Ndeffo Mbah et al.
EPIDEMICS (2014)
Development of a risk-based comparison methodology of carbon capture technologies
Dave Engel et al.
GREENHOUSE GASES-SCIENCE AND TECHNOLOGY (2014)
The Global Burden of Disease Study 2010: Interpretation and Implications for the Neglected Tropical Diseases
Peter J. Hotez et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Hepatotoxicity in Mice of a Novel Anti-parasite Drug Candidate Hydroxymethylnitrofurazone: A Comparison with Benznidazole
Carolina Davies et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Potential new clinical therapies for Chagas disease
Juan M. Bustamante et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
Into the valley of death: research to innovation
John Hudson et al.
DRUG DISCOVERY TODAY (2013)
Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats
D. Leonardi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)
Chagas' cardiomyopathy: The economic burden of an expensive and neglected disease
Abrao Abuhab et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Outbreak of acute Chagas disease associated with oral transmission in the Rio Negro region, Brazilian Amazon
Rita de Cassia de Souza-Lima et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
Prediction of emerging technologies based on analysis of the US patent citation network
Peter Erdi et al.
SCIENTOMETRICS (2013)
Patents and Innovation: Evidence from Economic History
Petra Moser
JOURNAL OF ECONOMIC PERSPECTIVES (2013)
The pharmaceutical technology landscape: A new form of technology roadmapping
Robert Tierney et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2013)
Social network analysis of patent infringement lawsuits
Hyoungshick Kim et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2013)
How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective
Paul G. Germann et al.
HUMAN GENOMICS (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Technology forecasting using matrix map and patent clustering
Sunghae Jun et al.
INDUSTRIAL MANAGEMENT & DATA SYSTEMS (2012)
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
Thomas P. C. Dorlo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Study of benznidazole-cyclodextrin inclusion complexes, cytotoxicity and trypanocidal activity
Magaly A. M. Lyra et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Modeling the economic value of a Chagas' disease therapeutic vaccine
Bruce Y. Lee et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
Patricia Severino et al.
JOURNAL OF DRUG DELIVERY (2012)
The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents
Orn Almarsson et al.
PHARMACEUTICAL PATENT ANALYST (2012)
BDDCS Applied to Over 900 Drugs
Leslie Z. Benet et al.
AAPS JOURNAL (2011)
Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled Release
Paulo Jose Salustio et al.
AAPS PHARMSCITECH (2011)
Public-private partnerships in neglected tropical disease control: The role of nongovernmental organisations
S. Bush et al.
ACTA TROPICA (2011)
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World
Luiz F. Oliveira et al.
ACTA TROPICA (2011)
New Prodrugs of the Antiprotozoal Drug Pentamidine
Joscha Kotthaus et al.
CHEMMEDCHEM (2011)
Recent advances in leishmaniasis treatment
Tatiana S. Tiuman et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Transdermal Evaporation Delivery System of Praziquantelfor Schistosomiasis Japonicum Chemotherapy
Lei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Neuroschistosomiasis: clinical symptoms and pathogenesis
Teresa Cristina A. Ferrari et al.
LANCET NEUROLOGY (2011)
Chronic phase of Chagas disease: why should it be treated? A comprehensive review
Jose Rodrigues Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2011)
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines.
Ashley J. Stevens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ethical and Scientific Considerations Regarding Animal Testing and Research
Hope R. Ferdowsian et al.
PLOS ONE (2011)
Patent citation network analysis of core and emerging technologies in Taiwan: 1997-2008
Ta-Shun Cho et al.
SCIENTOMETRICS (2011)
Patent data mining: A tool for accelerating HIV vaccine innovation
K. Clark et al.
VACCINE (2011)
Chemical patent information systems
Geoffrey M. Downs et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2011)
Why do academics engage with industry? The entrepreneurial university and individual motivations
Pablo D'Este et al.
JOURNAL OF TECHNOLOGY TRANSFER (2011)
Renal involvement in leishmaniasis: a review of the literature
Anna Clementi et al.
CLINICAL KIDNEY JOURNAL (2011)
Intellectual property rights: An overview and implications in pharmaceutical industry
Chandra Nath Saha et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2011)
Corporate foresight: Its three roles in enhancing the innovation capacity of a firm
Rene Rohrbeck et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2011)
Improving Outcome of Treatment of Kala-Azar by Supplementation of Amphotericin B with Physiologic Saline and Potassium Chloride
Chandeshwar P. Thakur et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Neglected tropical diseases
Nick Feasey et al.
BRITISH MEDICAL BULLETIN (2010)
Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease
Yves Jackson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice
Pavel Gershkovich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The Valley of Death as Context for Role Theory in Product Innovation
Stephen K. Markham et al.
JOURNAL OF PRODUCT INNOVATION MANAGEMENT (2010)
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro Jose Romanha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
PHYSICOCHEMICAL CHARACTERIZATION OF ANTICHAGASIC BENZNIDAZOLE
Flavia Pires Maximiano et al.
QUIMICA NOVA (2010)
Microcalorimetric and spectrographic studies on host-guest interactions of α-, β-, γ- and Mβ-cyclodextrin with resveratrol
Hui Li et al.
THERMOCHIMICA ACTA (2010)
The role of Product Development Partnerships in research and development for neglected diseases
M. Moran et al.
INTERNATIONAL HEALTH (2010)
Antimony Toxicity
Shyam Sundar et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2010)
Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
Ahmed M. Musa et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
The role of patenting activity for scientific research: A study of academic inventors from China's nanotechnology
Gangbo Wang et al.
JOURNAL OF INFORMETRICS (2010)
Growth behavior of publications and patents: A comparative study on selected Asian economies
Chan-Yuan Wong et al.
JOURNAL OF INFORMETRICS (2010)
Niosome: A future of targeted drug delivery systems
Kazi Masud Karim et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2010)
Effect of Cyclodextrin Complexation on the Aqueous Solubility and Solubility/Dose Ratio of Praziquantel
Stratos Maragos et al.
AAPS PHARMSCITECH (2009)
Studies on the Effect of Water-Soluble Polymers on Drug-Cyclodextrin Complex Solubility
Rajashree S. Hirlekar et al.
AAPS PHARMSCITECH (2009)
Technology readiness assessments: A retrospective
John C. Mankins
ACTA ASTRONAUTICA (2009)
THE CHRONIC GASTROINTESTINAL MANIFESTATIONS OF CHAGAS DISEASE
Nilce Mitiko Matsuda et al.
CLINICS (2009)
Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis
Jose A. Perez-Molina et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Pentavalent Antimonials: New Perspectives for Old Drugs
Frederic Frezard et al.
MOLECULES (2009)
Amphotericin B: side effects and toxicity
Rafael Laniado-Laborin et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
Traversing the Valley of Death: A Guide to Assessing Prospects for Translational Success
Barry S. Coller et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
An approach to discovering new technology opportunities: Keyword-based patent map approach
Sungjoo Lee et al.
TECHNOVATION (2009)
Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys
Paolo Bianciardi et al.
TOXICOLOGIC PATHOLOGY (2009)
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India
Piero Olliaro et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2009)
An Overview of Chagas Disease and the Role of Triatomines on Its Distribution in Brazil
Catarina A. C. Araujo et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2009)
Monitoring the organic structure of technology based on the patent development paths
Changwoo Choi et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2009)
Transdermal delivery of praziquantel: Effects of solvents on permeation across rabbit skin
Xin-Sheng Zheng et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Michael J. Doenhoff et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Visualization of patent analysis for emerging technology
Young Gil Kim et al.
EXPERT SYSTEMS WITH APPLICATIONS (2008)
Drug delivery and nanoparticles: Applications and hazards
Wim H. De Jong et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2008)
Translational research: Crossing the valley of death
Declan Butler
NATURE (2008)
Electron microscopy of trypanosomes - A historical view
Wanderley de Souza
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2008)
Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions
Ivo Santana Caldas et al.
PARASITOLOGY RESEARCH (2008)
Acute Chagas disease outbreak associated with oral transmission
Juarez Pereira Dias et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2008)
Nanoparticle strategies for the oral delivery of insulin
Christiane Damge et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Computational models to assign biopharmaceutics drug disposition classification from molecular structure
Akash Khandelwal et al.
PHARMACEUTICAL RESEARCH (2007)
Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework
Colin D. Mathers et al.
PLOS NEGLECTED TROPICAL DISEASES (2007)
Text mining techniques for patent analysis
Yuen-Hsien Tseng et al.
INFORMATION PROCESSING & MANAGEMENT (2007)
Role of the ABC transporter PRP1 (ABCC7) in pentamidine resistance in Leishmania amastigotes
Adriano C. Coelho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles
Abhijit A. Date et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Injectable paromomycin for visceral leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical aspects of the Chagas' heart disease
Gopikrishna Punukollu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Cyclodextrins and their pharmaceutical applications
Thorsteinn Loftsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting
Richard Reithinger et al.
BMC INFECTIOUS DISEASES (2007)
Development of miltefosine as an oral treatment for leishmaniasis
H. Sindermann et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Forecasting emerging technologies: Use of bibliometrics and patent analysis
Tugrul U. Daim et al.
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2006)
Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)
Jose A. Castro et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2006)
Patenting and US academic research in the 20th century: The world before and after Bayh-Dole
Bhaven N. Sampat
RESEARCH POLICY (2006)
University patenting and its effects on academic research: The emerging European evidence
Aldo Geuna et al.
RESEARCH POLICY (2006)
Oral bioavailability of a low molecular weight heparin using a polymeric delivery system
Valerie Hoffart et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion
Helene Vogelsinger et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov models
LS Wilson et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2005)
Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience
MG Chen
ACTA TROPICA (2005)
Evaluation of cyclodextrin solubilization of drugs
T Loftsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
In vitro characterization of some biopharmaceutical properties of praziquantel
GE Dinora et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
RM Mainardes et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide
RN Fedorak et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
M Lindenberg et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers
JS Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Reversible dilated cardiomyopathy related to amphotericin B therapy
PJ Danaher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
The effects of water-soluble polymers on cyclodextrins and cyclodextrin solubilization of drugs
T Loftsson et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2004)
New drugs for neglected diseases:: From pipeline to patients
B Pécoul
PLOS MEDICINE (2004)
Antimonials employed in the treatment of leishmaniaisis:: The state of the art
S Rath et al.
QUIMICA NOVA (2003)
Product R&D for neglected diseases - Twenty-seven years of WHO/TDR experience with public-private partnerships
RG Ridley
EMBO REPORTS (2003)
Nitroheterocyclic drugs with broad spectrum activity
W Raether et al.
PARASITOLOGY RESEARCH (2003)
Academic patents as an indicator of useful research? A new approach to measure academic inventiveness
M Meyer
RESEARCH EVALUATION (2003)
Experimental chemotherapy against Trypanosoma cruzi infection:: Essential role of endogenous interferon-γ in mediating parasitologic cure
AJ Romanha et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Linking science to technology: Using bibliographic references in patents to build linkage schemes
A Verbeek et al.
SCIENTOMETRICS (2002)
Links and impacts: The influence of public research on industrial R&D
WM Cohen et al.
MANAGEMENT SCIENCE (2002)
The African Green Monkey model for cutaneous and visceral leishmaniasis
JO Olobo et al.
TRENDS IN PARASITOLOGY (2001)
Crystal structure of paromomycin docked into the eubacterial ribosomal decoding a site
Q Vicens et al.
STRUCTURE (2001)
Mortality and costs of acute renal failure associated with amphotericin B therapy
DW Bates et al.
CLINICAL INFECTIOUS DISEASES (2001)
The growth of patenting and licensing by US universities: an assessment of the effects of the Bayh-Dole act of 1980
DC Mowery et al.
RESEARCH POLICY (2001)
Pulmonary extraction and accumulation of lipid formulations of amphotericin B
I Matot et al.
CRITICAL CARE MEDICINE (2000)
Multidimensional analysis of trends in patent activity
JC Doré et al.
SCIENTOMETRICS (2000)
分享论文
